EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies

Bavani Subramaniam iD, Wai Chin Chong iD, Aylar Babaei iD, Miriam Bornhorst, Chunchao Zhang, Roger Packer, Javad Nazarian iD

Cells · 10.12.2025 · 14 (24) · 1964

DOI: 10.3390/cells14241964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.12.2025. Verfasst von Bavani Subramaniam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC 20012, USA. Hauptthemen laut MEDLINE: Purine-Nucleoside Phosphorylase, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilbert Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homozygous deletion of the 9p21.3 genomic locus spanning the CDKN2A/B and MTAP genes is an event affecting 15% of cancers. While CDKN2A is a well-established tumor suppressor gene, the role of MTAP in tumorigenesis varies across cancer types. MTAP codes for methylthioadenosine phosphorylase, a key enzyme in the methionine salvage pathway, and its loss has been associated with several downstream synthetic vulnerabilities. Despite multiple efforts to exploit MTAP loss for targeted therapies, none of these efforts have yielded substantial results in clinical trials. In this review, we consolidate the existing literature along with our systematic analysis to provide an updated perspective on the incidence of MTAP loss in different cancers and elucidate its impact on metabolism, immune microenvironment, and tumor progression. In addition, we summarize the therapeutic strategies that have been investigated preclinically on MTAP-null tumors before and after the advent of functional genomic screening tools. We further assess the current landscape of clinical trials investigating MTAP-targeted inhibitors, evaluating their limitations and potential avenues for improvement. The insights gained from this review will inform future research directions beyond the promising PRMT5/MAT2A axis for rational combination therapies that would work synergistically to eradicate this devastating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purine-Nucleoside PhosphorylaseNeoplasmsHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

CDKN2Acancermetabolismmethylthioadenosine phosphorylasetherapy

Substanzen

Purine-Nucleoside Phosphorylase5'-methylthioadenosine phosphorylase

Autor:innen und Institutionen

  • Brain Tumor Institute, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC 20012, USA.
  • Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Children's Research Center, University Children's Hospital Zurich, 8008 Zurich, Switzerland.

ORCID-Profile: Bavani Subramaniam, Wai Chin Chong, Aylar Babaei, Javad Nazarian

Förderung

  • Gilbert Family Foundation

Zitieren

APA

Subramaniam, B., Chong, W. C., Babaei, A., Bornhorst, M., Zhang, C., Packer, R., & Nazarian, J. (2025). MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies. Cells, 14(24), 1964. https://doi.org/10.3390/cells14241964

Vancouver

Subramaniam B, Chong WC, Babaei A, Bornhorst M, Zhang C, Packer R, et al. MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies. Cells. 2025;14(24):1964. doi:10.3390/cells14241964

BibTeX
@article{Subramaniam2025,
  author = {Subramaniam, Bavani and Chong, Wai Chin and Babaei, Aylar and Bornhorst, Miriam and Zhang, Chunchao and Packer, Roger and Nazarian, Javad},
  title = {MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {24},
  pages = {1964},
  doi = {10.3390/cells14241964}
}
Kostenlos starten →